Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 12, 2010, Pages 1481-1486

  Zhang, Wei ^a   Gu, Yurong ^a   Chen, Youming ^a   Deng, Hong ^a   Chen, Lubiao ^a   Chen, Sui ^a   Zhang, Genglin ^a   Gao, Zhiliang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

bacterial translocation; cirrhosis; endotoxin; intestinal microflora; liver function

Indexed keywords

CARBON TETRACHLORIDE; ENDOTOXIN; NORFLOXACIN; PROBIOTIC AGENT;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENDOTOXEMIA; ENTEROBACTERIACEAE; ENTEROCOCCUS; INTESTINE FLORA; LACTOBACILLUS; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; CARBON TETRACHLORIDE; ENDOTOXEMIA; ENTEROBACTERIACEAE; ENTEROCOCCUS; INTESTINES; LACTOBACILLUS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; NORFLOXACIN; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78349304616     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32833eb8b0     Document Type: Article

References (34)

1. Mai V, Draganov PV. Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroenterol 2009; 15:81-85.
2. Othman M, Aguero R, Lin HC. Alterations in intestinal microbial flora and human disease. Curr Opin Gastroenterol 2008; 24:11-16.
3. Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the 'motor' of critical illness. Shock 2007; 28:384-393.
4. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009; 15:100-113.
5. Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma 2006; 60:126-133.
6. Almeida J, Galhenage S, Yu J, Kurtovic J, Riordan SM. Gutflora and bacterial translocation in chronic liver disease. World J Gastroenterol 2006; 12:1493-1502.
7. Floch MH, Katz J, Conn HO. Qualitative and quantitative relationships of the fecal flora in cirrhotic patients with portal systemic encephalopathy and following portacaval anastomosis. Gastroenterology 1970; 59:70-75.
8. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tracttothe mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979; 23: 403-411.
9. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41:422-433.
10. Berg RD. Bacterial translocation from the gastrointestinal tract. J Med 1992; 23:217-244.
11. Deitch EA, Ma WJ, Ma L, Berg R, Specian RD. Endotoxin-induced bacterial translocation: a study of mechanisms. Surgery 1989; 106:292-299.
12. Deitch EA, Specian RD, Berg RD. Endotoxin-induced bacterial translocation and mucosal permeability: role ofxanthine oxidase, complement activation, and macrophage products. Crit Care Med 1991; 19:785-791.
13. Walker RI. The contribution of intestinal endotoxin to mortality in hosts with compromised resistance: a review. Exp Hematol 1978; 6:172-184.
14. Morrison DC, Ryan JL. Bacterial endotoxins and host immune responses. Adv Immunol 1979; 28:293-450.
15. Li YT, Wang L, Chen Y, Chen YB, Wang HY, Wu ZW, Li LJ. Effects of gut microflora on hepatic damage after acute liver injury in rats. J Trauma 2010; 68:76-83.
16. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29:745-758.
17. Bauer TM, Fernandez J, Navasa M, Vila J, Rodes J. Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis. J Hepatol 2002; 36:501-506.
18. Runyon BA, Sugano S, Kanel G, Mellencamp MA. A rodent model of cirrhosis, ascites, and bacterial peritonitis. Gastroenterology 1991; 100:489-493.
19. Li XT, Qiu H. Lecture on Mitsuoka's method for analyzing intestinal microorganisms and metabolites. Chin J Miozoecol 1998; 10:3.
20. Hartemink R, Kok BJ, Weenk GH, Rombouts FM. Raffinose-Bifidobacterium (RB) agar; a new selective medium for Bifidobacteria. J Microbiol Methods 1996; 27:11.
21. Van Felius ID, Akkermans LM, Bosscha K,Verheem A, Harmsen W, Visser MR, Gooszen HG. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil 2003; 15:267-276.
22. Zhao HY, Wang HJ, Lu Z, Xu SZ. Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis 2004; 5:4.
23. Hoefs JC, Runyon BA. Spontaneous bacterial peritonitis. Dis Mon 1985; 31:1-48.
24. Llovet JM, Planas R, Morillas R, Quer JC, Cabre E, Boix J, et al. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 1993; 88:388-392.
25. Garcia-Tsao G. Spontaneous bacterial peritonitis. Gastroenterol Clin North Am 1992; 21:257-275.
26. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26:1372-1378.
27. Bauer TM, Schwacha H, Steinbruckner B, Brinkmann FE, Ditzen AK, Aponte JJ, et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 2002; 97:2364-2370.
28. Pardo A, Bartoli R, Lorenzo-Zuniga V, Planas R, Vinado B, Riba J, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology2000; 31:858-863.
29. Llovet JM, Bartoli R, March F, Planas R, Vinado B, Cabre E, et al. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol1998; 28:307-313.
30. De LeBlanc Ade M, Castillo NA, Perdigon G. Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection. Int J Food Microbiol 2010; 138:223-231.
31. Perdigon G, Alvarez S, Rachid M, Aguero G, Gobbato N. Immune system stimulation by probiotics. J Dairy Sci 1995; 78:1597-1606.
32. Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taura P, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001; 34:32-37.
33. Chan CC, Hwang SJ, Lee FY, Wang SS, Chang FY, Li CP, et al. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol 1997; 32:942-946.
34. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sorensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159:195-204.